Fusogard (Canada)

Company: Elanco

Fusobacterium Necrophorum Bacterin

For Use In Animals Only

Fusogard Indications

For use in healthy cattle 6 months of age or older as an aid in the reduction of clinical signs of footrot caused by Fusiformis necrophorus (Fusobacterium necrophorum).

ADJUVANT: SuprImm™.

Directions For Use

Shake well before using. Administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 3 weeks. Revaccinate annually or anytime endemic conditions exist, exposure is imminent, or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

Manufactured by Elanco US Inc., Fort Dodge, IA, USA.

USDA Vet. Biologics Est. Lic. No. 196.

For Elanco Canada Limited, Mississauga, Ontario, Canada L5N 0C9; 1-800-265-5475.

Fusogard, SuprImm, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

CPN: 1231054.7